Financial Counselors Inc. Purchases 1,166 Shares of Stryker Corporation (NYSE:SYK)

Financial Counselors Inc. raised its position in Stryker Corporation (NYSE:SYK - Free Report) by 3.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,677 shares of the medical technology company's stock after purchasing an additional 1,166 shares during the quarter. Financial Counselors Inc.'s holdings in Stryker were worth $14,025,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of Stryker in the fourth quarter worth about $1,710,744,000. GAMMA Investing LLC grew its stake in shares of Stryker by 43,226.8% in the 1st quarter. GAMMA Investing LLC now owns 2,074,922 shares of the medical technology company's stock valued at $772,390,000 after purchasing an additional 2,070,133 shares during the period. FMR LLC grew its stake in shares of Stryker by 10.0% in the 4th quarter. FMR LLC now owns 8,034,844 shares of the medical technology company's stock valued at $2,892,946,000 after purchasing an additional 727,850 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Stryker in the 4th quarter valued at approximately $154,140,000. Finally, Northern Trust Corp grew its stake in shares of Stryker by 13.2% in the 4th quarter. Northern Trust Corp now owns 3,606,237 shares of the medical technology company's stock valued at $1,298,426,000 after purchasing an additional 420,153 shares during the period. Hedge funds and other institutional investors own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on SYK. Wall Street Zen lowered Stryker from a "buy" rating to a "hold" rating in a research report on Friday, June 27th. Truist Financial increased their price target on Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research report on Monday, May 5th. Evercore ISI increased their price target on Stryker from $390.00 to $415.00 and gave the stock an "outperform" rating in a research report on Tuesday. BTIG Research set a $403.00 price target on Stryker and gave the stock a "buy" rating in a research report on Monday, April 14th. Finally, JMP Securities restated a "market perform" rating on shares of Stryker in a research report on Monday, May 5th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Stryker has an average rating of "Moderate Buy" and a consensus target price of $428.55.

Stryker Trading Down 0.7%

Shares of SYK stock traded down $2.86 during trading hours on Tuesday, reaching $389.65. The company had a trading volume of 1,195,342 shares, compared to its average volume of 1,473,612. The company has a 50 day moving average of $383.44 and a 200 day moving average of $376.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00. The firm has a market cap of $148.73 billion, a price-to-earnings ratio of 52.66, a P/E/G ratio of 2.98 and a beta of 0.91. Stryker Corporation has a 1-year low of $314.93 and a 1-year high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The business had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter in the prior year, the company earned $2.50 EPS. The firm's quarterly revenue was up 11.9% on a year-over-year basis. On average, equities research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend is Monday, June 30th. Stryker's dividend payout ratio is currently 45.41%.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the transaction, the director owned 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 5.20% of the stock is currently owned by corporate insiders.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.